These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 11027421

  • 21. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E, Letizia C, Proietti M, Aversa A, Menghi G, Rossi C, Torella E, Cotesta D, Petramala L, Bruzziches R, Spera G, Pisarri S, Salsano F.
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [Abstract] [Full Text] [Related]

  • 22. [Update on the treatment of systemic scleroderma].
    Priollet P, Cazalis P, Valleteau de Moulliac M.
    J Mal Vasc; 1987; 12(2):213-7. PubMed ID: 3295097
    [Abstract] [Full Text] [Related]

  • 23. [How to recognize scleroderma].
    Francès C, Ayoub N, Barete S.
    Rev Prat; 2002 Nov 01; 52(17):1884-90. PubMed ID: 12532864
    [Abstract] [Full Text] [Related]

  • 24. Ulnar artery involvement in systemic sclerosis (scleroderma).
    Taylor MH, McFadden JA, Bolster MB, Silver RM.
    J Rheumatol; 2002 Jan 01; 29(1):102-6. PubMed ID: 11824945
    [Abstract] [Full Text] [Related]

  • 25. Peripheral vasculopathy in patients with systemic sclerosis: difference in limited and diffuse subset of disease.
    Ostojić P, Damjanov N, Pavlov-Dolijanovic S, Radunović G.
    Clin Hemorheol Microcirc; 2004 Jan 01; 31(4):281-5. PubMed ID: 15567898
    [Abstract] [Full Text] [Related]

  • 26. The challenge of establishing treatment efficacy for cutaneous vascular manifestations of systemic sclerosis.
    Pauling JD.
    Expert Rev Clin Immunol; 2018 May 01; 14(5):431-442. PubMed ID: 29641934
    [Abstract] [Full Text] [Related]

  • 27. Severe refractory fingertip ulcerations in a patient with scleroderma: successful treatment with sildenafil.
    Colglazier CL, Sutej PG, O'Rourke KS.
    J Rheumatol; 2005 Dec 01; 32(12):2440-2. PubMed ID: 16331780
    [Abstract] [Full Text] [Related]

  • 28. Time to diagnosis in systemic sclerosis: is sex a factor?
    Hudson M, Thombs B, Baron M, Canadian Scleroderma Research Group.
    Arthritis Rheum; 2009 Feb 15; 61(2):274-8. PubMed ID: 19177534
    [Abstract] [Full Text] [Related]

  • 29. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
    Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M, EUSTAR Co-Authors.
    Ann Rheum Dis; 2009 May 15; 68(5):620-8. PubMed ID: 19147617
    [Abstract] [Full Text] [Related]

  • 30. Carotid thrombus formation and extension during anticoagulation: a case report of large vessel disease and hypercoagulable state in systemic sclerosis.
    Renard D, Heroum C.
    Acta Neurol Belg; 2007 Jun 15; 107(2):55-7. PubMed ID: 17710842
    [Abstract] [Full Text] [Related]

  • 31. Pulse cyclophosphamide decreases sympathetic postganglionic activity, controls alveolitis, and normalizes vascular tone dysfunction (Raynaud's phenomenon) in a case of early systemic sclerosis.
    Casale R, Generini S, Luppi F, Pignone A, Matucci-Cerinic M.
    Arthritis Rheum; 2004 Aug 15; 51(4):665-9. PubMed ID: 15334442
    [No Abstract] [Full Text] [Related]

  • 32. [Systemic sclerosis].
    Tamborrini G, Distler M, Distler O.
    Med Monatsschr Pharm; 2008 May 15; 31(5):162-70; quiz 171-2. PubMed ID: 18552072
    [Abstract] [Full Text] [Related]

  • 33. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy.
    Matucci-Cerinic M, Allanore Y, Czirják L, Tyndall A, Müller-Ladner U, Denton C, Valentini G, Distler O, Fligelstone K, Tyrrel-Kennedy A, Farge D, Kowal-Bielecka O, van den Hoogen F, Cutolo M, Sampaio-Barros PD, Nash P, Takehara K, Furst DE.
    Ann Rheum Dis; 2009 Sep 15; 68(9):1377-80. PubMed ID: 19674983
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of oral methotrexate in the treatment of systemic sclerosis.
    Krishna Sumanth M, Sharma VK, Khaitan BK, Kapoor A, Tejasvi T.
    Int J Dermatol; 2007 Feb 15; 46(2):218-23. PubMed ID: 17269983
    [Abstract] [Full Text] [Related]

  • 35. Raynaud's phenomenon in mixed connective tissue disease.
    Grader-Beck T, Wigley FM.
    Rheum Dis Clin North Am; 2005 Aug 15; 31(3):465-81, vi. PubMed ID: 16084319
    [Abstract] [Full Text] [Related]

  • 36. Therapeutic options for systemic sclerosis.
    Akerkar SM, Bichile LS.
    Indian J Dermatol Venereol Leprol; 2004 Aug 15; 70(2):67-75. PubMed ID: 17642568
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Progressive systemic sclerosis associated with anti-myeloperoxidase ANCA vasculitis with renal and cutaneous involvement].
    Martínez Ara J, Picazo ML, Torre A, Pascual D, Díaz Rodríguez C, Riñón C.
    Nefrologia; 2000 Aug 15; 20(4):383-6. PubMed ID: 11039266
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.